ListarInstituto de Biomedicina de Sevilla (IBIS) por materia "Cancer treatment"
Mostrando ítems 1-1 de 1
-
Artículo
Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src.
(Impact Journals, 2016-04-20)Despite the development of new antineoplastic agents for the treatment of colorectal cancer (CRC), oxaliplatin and ...